These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 21593487)
1. High-content screening for chemical modulators of embryonal carcinoma cell differentiation and survival. Barbaric I; Jones M; Harley DJ; Gokhale PJ; Andrews PW J Biomol Screen; 2011 Jul; 16(6):603-17. PubMed ID: 21593487 [TBL] [Abstract][Full Text] [Related]
2. Novel regulators of stem cell fates identified by a multivariate phenotype screen of small compounds on human embryonic stem cell colonies. Barbaric I; Gokhale PJ; Jones M; Glen A; Baker D; Andrews PW Stem Cell Res; 2010 Sep; 5(2):104-19. PubMed ID: 20542750 [TBL] [Abstract][Full Text] [Related]
3. High content screening for compounds that induce early stages of human embryonic stem cell differentiation. Jee J; Jeon H; Hwang D; Sommer P; Park Z; Cechetto J; Dorval T Comb Chem High Throughput Screen; 2012 Sep; 15(8):656-65. PubMed ID: 22364550 [TBL] [Abstract][Full Text] [Related]
4. Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells. Choi SC; Choi JH; Park CY; Ahn CM; Hong SJ; Lim DS J Cell Physiol; 2012 Nov; 227(11):3678-92. PubMed ID: 22378194 [TBL] [Abstract][Full Text] [Related]
5. Extrinsic factors derived from mouse embryonal carcinoma cell lines maintain pluripotency of mouse embryonic stem cells through a novel signal pathway. Kawazoe S; Ikeda N; Miki K; Shibuya M; Morikawa K; Nakano S; Oshimura M; Hisatome I; Shirayoshi Y Dev Growth Differ; 2009 Feb; 51(2):81-93. PubMed ID: 19207180 [TBL] [Abstract][Full Text] [Related]
6. The CDK inhibitor p27 enhances neural differentiation in pluripotent NTERA2 human EC cells, but does not permit differentiation of 2102Ep nullipotent human EC cells. Bahrami AR; Matin MM; Andrews PW Mech Dev; 2005 Sep; 122(9):1034-42. PubMed ID: 16023837 [TBL] [Abstract][Full Text] [Related]
7. A data integration approach to mapping OCT4 gene regulatory networks operative in embryonic stem cells and embryonal carcinoma cells. Jung M; Peterson H; Chavez L; Kahlem P; Lehrach H; Vilo J; Adjaye J PLoS One; 2010 May; 5(5):e10709. PubMed ID: 20505756 [TBL] [Abstract][Full Text] [Related]
8. High-content screening of feeder-free human embryonic stem cells to identify pro-survival small molecules. Andrews PD; Becroft M; Aspegren A; Gilmour J; James MJ; McRae S; Kime R; Allcock RW; Abraham A; Jiang Z; Strehl R; Mountford JC; Milligan G; Houslay MD; Adams DR; Frearson JA Biochem J; 2010 Nov; 432(1):21-33. PubMed ID: 20854259 [TBL] [Abstract][Full Text] [Related]
9. Small molecule screening with laser cytometry can be used to identify pro-survival molecules in human embryonic stem cells. Sherman SP; Pyle AD PLoS One; 2013; 8(1):e54948. PubMed ID: 23383009 [TBL] [Abstract][Full Text] [Related]
10. MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cells. Sulaiman G; Cooke A; Ffrench B; Gasch C; Abdullai OA; O'Connor K; Elbaruni S; Blackshields G; Spillane C; Keegan H; McEneaney V; Knittel R; Rogers A; Jeffery IB; Doyle B; Bates M; d'Adhemar C; Lee MY; Campbell EL; Moynagh PN; Higgins DG; O'Toole S; O'Neill L; O'Leary JJ; Gallagher MF Cell Death Differ; 2017 Nov; 24(11):1975-1986. PubMed ID: 28885616 [TBL] [Abstract][Full Text] [Related]
12. Transforming pluripotency: an exon-level study of malignancy-specific transcripts in human embryonal carcinoma and embryonic stem cells. Alagaratnam S; Harrison N; Bakken AC; Hoff AM; Jones M; Sveen A; Moore HD; Andrews PW; Lothe RA; Skotheim RI Stem Cells Dev; 2013 Apr; 22(7):1136-46. PubMed ID: 23137282 [TBL] [Abstract][Full Text] [Related]
13. High-throughput identification of small molecules that affect human embryonic vascular development. Vazão H; Rosa S; Barata T; Costa R; Pitrez PR; Honório I; de Vries MR; Papatsenko D; Benedito R; Saris D; Khademhosseini A; Quax PH; Pereira CF; Mercader N; Fernandes H; Ferreira L Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3022-E3031. PubMed ID: 28348206 [TBL] [Abstract][Full Text] [Related]
14. High-content screening of small compounds on human embryonic stem cells. Barbaric I; Gokhale PJ; Andrews PW Biochem Soc Trans; 2010 Aug; 38(4):1046-50. PubMed ID: 20659001 [TBL] [Abstract][Full Text] [Related]
15. Rho-associated kinase inhibitors promote the cardiac differentiation of embryonic and induced pluripotent stem cells. Cheng YT; Yeih DF; Liang SM; Chien CY; Yu YL; Ko BS; Jan YJ; Kuo CC; Sung LY; Shyue SK; Chen MF; Yet SF; Wu KK; Liou JY Int J Cardiol; 2015 Dec; 201():441-8. PubMed ID: 26313863 [TBL] [Abstract][Full Text] [Related]
16. Aza-induced cardiomyocyte differentiation of P19 EC-cells by epigenetic co-regulation and ERK signaling. Abbey D; Seshagiri PB Gene; 2013 Sep; 526(2):364-73. PubMed ID: 23747406 [TBL] [Abstract][Full Text] [Related]
17. A Protocol for In Vitro High-Throughput Chemical Susceptibility Screening in Differentiating NT2 Stem Cells. Menzner AK; Gilbert DF Methods Mol Biol; 2017; 1601():61-70. PubMed ID: 28470517 [TBL] [Abstract][Full Text] [Related]
18. Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells. Menzner AK; Abolpour Mofrad S; Friedrich O; Gilbert DF Toxicology; 2015 Dec; 338():69-76. PubMed ID: 26498558 [TBL] [Abstract][Full Text] [Related]